| Stent for Life Initiative: leading example in building STEMI systems of care in emerging countries Z Kaifoszova, P Kala, T Alexander, Y Zhang, Y Huo, A Snyders, R Delport, ... EuroIntervention 10 (Suppl T), T87-T95, 2014 | 71 | 2014 |
| Role of microparticles in cardiovascular disease: implications for endothelial dysfunction, thrombosis, and inflammation LM Lugo-Gavidia, D Burger, VB Matthews, JM Nolde, M Galindo Kiuchi, ... Hypertension 77 (6), 1825-1844, 2021 | 42 | 2021 |
| New approaches in the management of sudden cardiac death in patients with heart failure—targeting the sympathetic nervous system MG Kiuchi, JM Nolde, H Villacorta, R Carnagarin, JJSY Chan, ... International Journal of Molecular Sciences 20 (10), 2430, 2019 | 32 | 2019 |
| Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation R Carnagarin, K Tan, L Adams, VB Matthews, MG Kiuchi, ... International Journal of Molecular Sciences 22 (8), 4241, 2021 | 27 | 2021 |
| Sympathetic activation in hypertensive chronic kidney disease–a stimulus for cardiac arrhythmias and sudden cardiac death? MG Kiuchi, JK Ho, JM Nolde, LML Gavidia, R Carnagarin, VB Matthews, ... Frontiers in physiology 10, 469668, 2020 | 27 | 2020 |
| Dual antiplatelet therapy after coronary stent implantation: individualizing the optimal duration LM Lugo, JL Ferreiro Journal of Cardiology 72 (2), 94-104, 2018 | 26 | 2018 |
| High and low on-treatment platelet reactivity to P2Y12 inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention JL Ferreiro, D Vivas, JM De La Hera, AL Marcano, LM Lugo, ... Thrombosis Research 175, 95-101, 2019 | 19 | 2019 |
| Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension S Frost, JM Nolde, J Chan, A Joyson, C Gregory, R Carnagarin, LY Herat, ... Scientific reports 11 (1), 1001, 2021 | 15 | 2021 |
| Bexagliflozin for type 2 diabetes: an overview of the data O Azzam, R Carnagarin, LM Lugo-Gavidia, J Nolde, VB Matthews, ... Expert Opinion on Pharmacotherapy 22 (16), 2095-2103, 2021 | 13 | 2021 |
| Nocturnal hypertension: a common phenotype in a tertiary clinical setting associated with increased arterial stiffness and central blood pressure JM Nolde, MG Kiuchi, LM Lugo-Gavidia, JK Ho, J Chan, VB Matthews, ... Journal of Hypertension 39 (2), 250-258, 2021 | 13 | 2021 |
| Capillary vascular density in the retina of hypertensive patients is associated with a non-dipping pattern independent of mean ambulatory blood pressure JM Nolde, S Frost, D Kannenkeril, LM Lugo-Gavidia, J Chan, A Joyson, ... Journal of Hypertension 39 (9), 1826-1834, 2021 | 10 | 2021 |
| Atypical presentation of diffuse large B-cell non-Hodgkin lymphoma MA Alcocer-Gamba, S León-González, E Castro-Montes, LM Loarca-Piña, ... Revista Médica del Instituto Mexicano del Seguro Social 53 (2), 232-238, 2015 | 10 | 2015 |
| A standarized protocol for evaluation of large extracellular vesicles using the attune™ NXT system LM Lugo-Gavidia, D Burger, E Bosio, S Robinson, J Nolde, R Carnagarin, ... Journal of Immunological Methods 499, 113170, 2021 | 8 | 2021 |
| Increased pulse wave velocity in patients with an orthostatic blood pressure rise independent of other cardiovascular risk factors JM Nolde, LM Lugo-Gavidia, D Kannenkeril, J Chan, VB Matthews, ... Journal of Hypertension 39 (7), 1352-1360, 2021 | 8 | 2021 |
| Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy R Carnagarin, JM Nolde, NC Ward, LM Lugo‐Gavidia, J Chan, ... The Journal of Clinical Hypertension 23 (7), 1380-1389, 2021 | 7 | 2021 |
| New molecules for treating resistant hypertension: a clinical perspective O Azzam, MG Kiuchi, JK Ho, VB Matthews, LML Gavidia, JM Nolde, ... Current Hypertension Reports 21, 1-12, 2019 | 7 | 2019 |
| Tratamiento endovascular exitoso del síndrome de cascanueces con stent autoexpandible MA Alcocer-Gamba, JA Martínez-Chávez, M Alcántara-Razo, G Eid-Lidt, ... Archivos de cardiología de México 82 (4), 303-307, 2012 | 7 | 2012 |
| Antithrombotic therapy after transcatheter aortic valve implantation LM Lugo, R Romaguera, JA Gómez-Hospital, JL Ferreiro European Cardiology Review 15, 2020 | 6 | 2020 |
| Antithrombotic therapy after transcatheter aortic valve implantation. LM Lugo, R Romaguera, FJL Gomez-Hospital JA Eur Cardiol 15, 1-8, 2020 | 6 | 2020 |
| Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health LM Lugo‐Gavidia, R Carnagarin, D Burger, JM Nolde, J Chan, ... The Journal of Clinical Hypertension 24 (6), 738-749, 2022 | 5 | 2022 |
